Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-56,990
Closed -$6.81M 2151
2026
Q1
$6.81M Sell
56,990
-74,016
-56% -$9.71M 0.05% 341
2025
Q4
$17.8M Buy
+131,006
New +$18.8M 0.14% 120
2025
Q3
Sell
-22,210
Closed -$2.87M 2093
2025
Q2
$2.87M Buy
+22,210
New +$2.69M 0.03% 611
2025
Q1
Sell
-45,704
Closed -$5.3M 2076
2024
Q4
$5.3M Sell
45,704
-39,076
-46% -$4.94M 0.04% 429
2024
Q3
$11.4M Buy
84,780
+18,183
+27% +$2.43M 0.07% 216
2024
Q2
$9.03M Buy
+66,597
New +$9.06M 0.06% 274
2024
Q1
Sell
-45,589
Closed -$5.21M 2026
2023
Q4
$5.21M Buy
45,589
+39,470
+645% +$3.94M 0.03% 335
2023
Q3
$557K Sell
6,119
-69,048
-92% -$7.12M 0.01% 1201
2023
Q2
$8.46M Sell
75,167
-123,581
-62% -$13.1M 0.07% 287
2023
Q1
$20.8M Buy
+198,748
New +$20.8M 0.17% 99
2022
Q4
Sell
-149,269
Closed -$13M 2213
2022
Q3
$13M Buy
+149,269
New +$13.6M 0.17% 150
2022
Q1
Sell
-94,657
Closed -$11.4M 2733
2021
Q4
$11.4M Buy
+94,657
New +$11.7M 0.12% 185
2021
Q2
Sell
-46,553
Closed -$4.9M 2876
2021
Q1
$4.9M Buy
46,553
+42,736
+1,120% +$4.33M 0.07% 275
2020
Q4
$389K Buy
+3,817
New +$359K ﹤0.01% 1400
2020
Q3
Sell
-9,491
Closed -$617K 2291
2020
Q2
$617K Buy
9,491
+862
+10% +$56.9K 0.02% 972
2020
Q1
$562K Buy
+8,629
New +$680K 0.03% 445
2019
Q4
Sell
-5,875
Closed -$468K 1939
2019
Q3
$468K Buy
+5,875
New +$462K 0.02% 689

Other funds holding XYL

Michael Gelband's XYL Position: Q2 2026 in Review

Michael Gelband sold out of Xylem (XYL) in Q2 2026, closing a stake of 56,990 shares — an estimated $6.81M sold.

Michael Gelband first reported a position in XYL in Q3 2019 and held it in 17 quarters. The position peaked at $20.8M in Q1 2023. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Michael Gelband reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 56,990 Xylem shares in Q2 2026, an estimated $6.81M.
  • Michael Gelband first reported a position in Xylem in Q3 2019 and held it in 17 quarters.
  • Michael Gelband's Xylem position peaked at $20.8M in Q1 2023.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.